STOCK TITAN

Resolute Holdings Management, Inc. Form 4 Filings

RHLD NYSE

Every Form 4 that Resolute Holdings Management, Inc. (RHLD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow RHLD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RHLD filings page.

Rhea-AI Summary

Resolute Holdings Management, Inc. (RHLD) reported that its Chief Financial Officer, Kurt Schoen, purchased 375 shares of common stock in an open-market transaction on 2026-08-20 at a weighted average price of $117.84 per share. Following this purchase, he directly holds 3,225 shares of RHLD common stock.

Rhea-AI Summary

Resolute Holdings Management, Inc. director Jane J. Thompson received a grant of stock options covering 1,452 shares of common stock. The options have an exercise price of $129.19 per share and expire on June 11, 2036. They vest in four equal 25% annual installments starting June 11, 2027.

Rhea-AI Summary

Resolute Holdings Management, Inc. director Krishna Mikkilineni received a grant of stock options covering 1,452 shares of common stock. The options have an exercise price of $129.19 per share, expire on June 11, 2036, and were granted at no cost as compensation rather than through a market purchase.

All 1,452 options remain held after the grant. According to the footnote, the award will vest in four equal annual installments of 25%, beginning on June 11, 2027 and continuing on each of the first, second, and third anniversaries of that date.

Rhea-AI Summary

Resolute Holdings Management, Inc. director Timothy O. Mahoney received two stock option grants for a total of 4,356 options to buy common stock at an exercise price of $129.19 per share. The options vest in four equal 25% installments starting on June 11, 2027. These awards were issued under the company’s non-employee director compensation policy in lieu of a $50,000 annual cash retainer at the director’s election.

Rhea-AI Summary

Resolute Holdings Management, Inc. director James Mark R. received a grant of stock options covering 1,452 shares of common stock on June 11, 2026. The options have an exercise price of $129.19 per share, expire on June 11, 2036, and represent compensation rather than an open-market trade. Following the award, he holds 1,452 stock options, which vest in four annual 25% installments starting June 11, 2027.

Rhea-AI Summary

Resolute Holdings Management, Inc. director Brian F. Hughes received a grant of stock options covering 1,452 shares of common stock on June 11, 2026. The options have an exercise price of $129.19 per share and expire on June 11, 2036.

The grant is compensation-related, with no cash paid by Hughes at grant. According to the footnote, the options vest in four equal annual installments of 25% each, beginning on June 11, 2027 and on the first, second, and third anniversaries of that date. Following this grant, Hughes holds 1,452 options directly.

Rhea-AI Summary

Resolute Holdings Management, Inc. director Hewett Wayne M. received equity compensation in the form of stock options rather than cash. On June 11, 2026 he was granted 726 and 3,630 stock options, each with an exercise price of $129.19 per share, expiring on June 11, 2036. The options vest in four equal annual installments of 25% starting on June 11, 2027. According to the company’s non-employee director compensation policy, these awards were issued in lieu of a $50,000 annual cash retainer at the director’s election.

Rhea-AI Summary

Resolute Holdings Management, Inc. director Paul Galant received a grant of stock options covering 1,452 shares of common stock on June 11, 2026. The options have an exercise price of $129.19 per share and expire on June 11, 2036.

The options vest in four equal annual installments of 25% each starting on June 11, 2027

Rhea-AI Summary

Resolute Holdings Management, Inc. director Roger Fradin received a grant of stock options covering 1,452 shares of common stock at an exercise price of $129.19 per share. These options were awarded at no cost to him and represent compensation, not an open-market trade.

The options vest in four equal annual installments of 25% each, starting on June 11, 2027 and on the first, second, and third anniversaries of that date, and will expire on June 11, 2036 if not exercised.

Rhea-AI Summary

Resolute Holdings Management, Inc. director Joseph J. DeAngelo received a grant of stock options on Common Stock. The award covers 1,452 options with an exercise price of $129.19 per share and no cash paid at grant. These options vest in four equal annual installments of 25% starting on June 11, 2027 and on each of the next three anniversaries, and will expire on June 11, 2036 if not exercised.

Rhea-AI Summary

Resolute Holdings Management, Inc. reported that director John D. Cote received a grant of stock options. The award covers 1,452 options to buy Resolute Holdings common stock at an exercise price of $129.19 per share, expiring on June 11, 2036.

These options were granted as compensation and not purchased on the open market. Following the grant, Cote holds 1,452 derivative securities of this type. According to the footnote, the options vest in four equal annual installments of 25% starting on June 11, 2027 and on each of the next three anniversaries.

Rhea-AI Summary

Resolute Holdings Management, Inc. director Mikkilineni Krishna reported an open-market purchase of common stock. On May 14, 2026, the director bought 921.396 shares of common stock at $108.5200 per share. After this transaction, direct holdings total 1,145.396 shares, which includes 224 shares that were inadvertently omitted from prior reports, according to the footnote. No derivative securities are reported in this filing.

Rhea-AI Summary

Resolute Holdings Management, Inc. Chief Financial Officer Kurt Schoen reported an open-market purchase of the company’s common stock. On May 13, 2026, he bought 450 shares at a weighted average price of $108.34 per share, in multiple trades between $108.32 and $108.34. Following this transaction, he directly holds 2,850 shares.

Rhea-AI Summary

Resolute Holdings Management, Inc. director Jane J. Thompson reported an open-market sale of 1,850 shares of common stock on March 17, 2026 at an average price of $124.42 per share. After the sale, she directly holds 6,273 shares of Resolute Holdings common stock.

According to the footnote, these shares were sold to cover personal income tax obligations related to the vesting of equity awards and the company’s spin-off on February 28, 2025, indicating the transaction was tax-driven rather than a discretionary portfolio change.

Rhea-AI Summary

Resolute Holdings Management, Inc. Chief Financial Officer Kurt Schoen bought 500 shares of common stock in an open-market transaction. The shares were purchased on March 17, 2026 at a weighted average price of $141.51 per share, with actual prices ranging from $141.22 to $141.52. Following this trade, he directly owns 2,400 shares of Resolute Holdings common stock.

Rhea-AI Summary

Resolute Holdings Management, Inc. director John D. Cote reported open-market purchases of a total of 552 shares of common stock on March 17, 2026, at prices ranging from $141.50 to $144.50 per share. These shares are held indirectly through his spouse.

The filing also shows substantial indirect holdings of common stock through entities associated with Cote, including 4,107,534 shares held by Resolute Compo Holdings LLC, 73,330 shares held by Tungsten 2024 LLC, and 125,000 shares held by Ridge Valley LLC, with beneficial ownership disclaimed except to the extent of pecuniary interest.

Rhea-AI Summary

Resolute Holdings Management, Inc. (RHLD) reported an insider stock purchase by its Chief Financial Officer, Kurt Schoen. On 11/18/2025, the CFO bought 900 shares of common stock in an open market transaction coded "P" at a price of $149.23 per share. After this transaction, he beneficially owns 1,900 shares of Resolute common stock in direct ownership form. This filing is a routine Form 4 disclosure showing an increase in the executive’s personal investment in the company.

Rhea-AI Summary

Resolute Holdings Management, Inc. (RHLD) director Timothy Mahoney reported a purchase of common stock. On 11/18/2025, he acquired 3,268.305 shares of Resolute Holdings common stock in an open-market transaction coded "P" (purchase) at a weighted average price of $152.98 per share. The filing notes that the shares were bought in multiple trades at prices ranging from $152.605 to $153.00. Following this transaction, Mahoney beneficially owns 9,207.305 shares of Resolute Holdings common stock, held directly.

Rhea-AI Summary

Resolute Holdings Management, Inc. (RHLD) director Timothy Mahoney reported open‑market purchases of common stock on 11/07/2025 across multiple trades. Transactions were executed at weighted average prices, with disclosed ranges spanning $161.70–$171.18 per share, including specific fills at $164.23, $165.26, $166.72, $167.83, $168.95, and $170.08. Following these purchases, his direct beneficial ownership stood at 5,939 shares.

Rhea-AI Summary

Resolute Holdings Management, Inc. (RHLD) reported an insider purchase. A Form 4 shows CFO Kurt Schoen acquired 1,000 shares of common stock on 11/07/2025 at a weighted average price of $164.95.

The filing notes the shares were bought in multiple transactions within a price range of $164.86–$165.00. Following the transaction, Schoen beneficially owns 1,000 shares, held directly.